These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24500706

  • 1. Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome.
    Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S.
    Pediatr Nephrol; 2014 Jul; 29(7):1181-7. PubMed ID: 24500706
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.
    Yokota S, Kamei K, Fujinaga S, Hamada R, Inaba A, Nishi K, Sato M, Ogura M, Sakuraya K, Ito S.
    Pediatr Nephrol; 2024 Oct; 39(10):2979-2988. PubMed ID: 38834892
    [Abstract] [Full Text] [Related]

  • 3. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
    Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K.
    Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879
    [Abstract] [Full Text] [Related]

  • 4. Children with Steroid-resistant Nephrotic Syndrome: Long-term Outcomes of Sequential Steroid Therapy.
    Zhang H, Wang Z, Dong LQ, Guo YN.
    Biomed Environ Sci; 2016 Sep; 29(9):650-655. PubMed ID: 27806747
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.
    Mori K, Honda M, Ikeda M.
    Pediatr Nephrol; 2004 Nov; 19(11):1232-6. PubMed ID: 15322892
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B, Mahapatra TK, Mondal N.
    Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
    [Abstract] [Full Text] [Related]

  • 7. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
    Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
    Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
    Pediatr Nephrol; 2019 Feb; 34(2):353-357. PubMed ID: 30426219
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
    Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
    Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
    [Abstract] [Full Text] [Related]

  • 10. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.
    Nakagawa T, Shiratori A, Kawaba Y, Kanda K, Tanaka R.
    Pediatr Int; 2016 Oct 21; 58(10):1003-1008. PubMed ID: 26865241
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.
    Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A.
    Clin J Am Soc Nephrol; 2010 Dec 21; 5(12):2207-12. PubMed ID: 20798255
    [Abstract] [Full Text] [Related]

  • 13. Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome.
    Fujinaga S, Hara T.
    Pediatr Nephrol; 2014 Jul 21; 29(7):1291-2. PubMed ID: 24633445
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
    Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
    [Abstract] [Full Text] [Related]

  • 15. The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome.
    Hirano D, Fujinaga S, Nishizaki N.
    Clin Nephrol; 2012 Jun 04; 77(6):510-2. PubMed ID: 22595396
    [No Abstract] [Full Text] [Related]

  • 16. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.
    Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S.
    Pediatr Nephrol; 2010 May 04; 25(5):957-9. PubMed ID: 20033219
    [Abstract] [Full Text] [Related]

  • 17. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
    Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Picazo ML, Navarro M.
    Pediatr Nephrol; 2007 Nov 04; 22(11):1875-80. PubMed ID: 17876609
    [Abstract] [Full Text] [Related]

  • 18. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.
    Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM.
    Clin J Am Soc Nephrol; 2011 Jun 04; 6(6):1308-15. PubMed ID: 21566104
    [Abstract] [Full Text] [Related]

  • 19. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K, Sallam HT, Hakim AA, Al-Attiyah R.
    Saudi J Kidney Dis Transpl; 2012 Sep 04; 23(5):973-8. PubMed ID: 22982909
    [Abstract] [Full Text] [Related]

  • 20. Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).
    Nozu K, Sako M, Tanaka S, Kano Y, Ohwada Y, Morohashi T, Hamada R, Ohtsuka Y, Oka M, Kamei K, Inaba A, Ito S, Sakai T, Kaito H, Shima Y, Ishikura K, Nakamura H, Nakanishi K, Horinouchi T, Konishi A, Omori T, Iijima K.
    Clin Exp Nephrol; 2024 Apr 04; 28(4):337-348. PubMed ID: 38010466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.